Why the study?
Panax ginseng is used for its pharmacological activities, but its effects on mortality-related hypomagnesemia, hyperlactatemia, and metabolic acidosis in diabetes required investigation.
Does Panax ginseng improve hypomagnesemia, hyperlactatemia, and metabolic acidosis in an alloxan-induced diabetic rabbit model?
Does Panax ginseng improve hypomagnesemia, hyperlactatemia, and metabolic acidosis in an alloxan-induced diabetic rabbit model?
Long-term oral intake of Panax ginseng improves glycemic control, electrolytes, and acid-base balance in a rabbit model of type 1 diabetes.
Answers are grounded in this paper and cite their sources.
Animal findings on ginseng in diabetic rabbits should not change practice; leaves open translation to human metabolic complications.
OBJECTIVES: (PG) widely used for its various pharmacological activities, including effects on diabetes and its complications. This study aims to investigate the effect of PG on mortality-related hypomagnesemia, hyperlactatemia, metabolic acidosis, and other diabetes-induced abnormalities. MATERIALS AND METHODS: Type 1 diabetes was induced by IV injection of alloxan monohydrate 110 mg/kg into New Zealand white rabbits weighing 2-2.5 kg. PG was supplied in drinking water for 20 weeks. The effects of the PG treatment on diabetes were evaluated through hematological and biochemical analysis including ELISA assays for insulin and glycated haemoglobin A1c (HBA1c) before and after PG extract was supplied. Moreover, PG showed hepato- and renoprotective effect. Likewise, electrolytes, lipid and protein profile were improved. CONCLUSION: The biochemical and hematological analysis data demonstrate that the PG is effective to alleviate the diabetes serious signs.
No takes yet. Share an insight, caveat, or question.
Adam et al. (2019) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: